{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:36Z","timestamp":1791409896163,"version":"4.3.3"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2021\/43\/B\/NZ7\/01732"],"award-info":[{"award-number":["UMO-2021\/43\/B\/NZ7\/01732"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["670\/2024"],"award-info":[{"award-number":["670\/2024"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110417","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:54:50Z","timestamp":1787327690000},"page":"110417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["D2AAK1 derivatives as neuroprotective agents: Synthesis and structural and pharmacological evaluation"],"prefix":"10.1016","volume":"181","author":[{"given":"Micha\u0142 K.","family":"Jastrz\u0119bski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pietrzak-Mitura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Bartyzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M.","family":"Targowska-Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Karcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Wronikowska-Denysiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Olejarz-Maciej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Sumara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Dr\u0105czkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Fornal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz M.","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka A.","family":"Kaczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110417_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuint.2015.11.001","article-title":"Neurodegenerative diseases: from available treatments to prospective herbal therapy","volume":"95","author":"Solanki","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2026.110417_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/fn.2020.96707","article-title":"What causes neurodegenerative disease?","volume":"58","author":"Armstrong","year":"2020","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/13543784.16.1.59","article-title":"An update on pharmacological approaches to neurodegenerative diseases","volume":"16","author":"Scatena","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2026.110417_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110417_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1006089","article-title":"Analysis of shared underlying mechanism in neurodegenerative disease","volume":"14","author":"Butler","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312613","article-title":"Decoding neurodegeneration: a review of molecular mechanisms and therapeutic advances in Alzheimer's, Parkinson's, and ALS","volume":"25","author":"Toader","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0040","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1021\/jm3015926","article-title":"Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers","volume":"56","author":"Trippier","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0045","article-title":"Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases, Evid","volume":"2020","author":"Mohd Sairazi","year":"2020","journal-title":"Based Complement. Alternat. Med."},{"key":"10.1016\/j.bioorg.2026.110417_bb0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110417_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/nmt.14.51","article-title":"Working memory and memory loss in neurodegenerative disease","volume":"5","author":"Sandry","year":"2015","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.bioorg.2026.110417_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.apsb.2023.10.007","article-title":"Effects of small molecules on neurogenesis: neuronal proliferation and differentiation","volume":"14","author":"Jastrz\u0119bski","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.110417_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Bl\u00e1zquez","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0070","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/molecules30142975","article-title":"Dual inhibitors of acetylcholinesterase and monoamine oxidase-B for the treatment of Alzheimer's disease","volume":"30","author":"Asim","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2270781","article-title":"Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease","volume":"38","author":"Zou","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0080","doi-asserted-by":"crossref","first-page":"24830","DOI":"10.1021\/acs.jmedchem.5c02894","article-title":"Fragment-to-lead medicinal chemistry publications in 2024: a tenth annual perspective","volume":"68","author":"Twigg","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2025.100233","article-title":"Fragment-based drug discovery: a graphical review","volume":"9","author":"AlKharboush","year":"2025","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110417_bb0090","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1021\/acs.jmedchem.6b00307","article-title":"Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-dioxide derivative Verubecestat (MK-8931)\u2013a \u03b2-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer's disease","volume":"59","author":"Scott","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cbpa.2013.04.016","article-title":"Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story","volume":"17","author":"Stamford","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0100","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1038\/s41380-021-01166-2","article-title":"BACE1 controls synaptic function through modulating release of synaptic vesicles","volume":"26","author":"Das","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bioorg.2026.110417_bb0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/cmdc.201500599","article-title":"Structure-based virtual screening for dopamine D2 receptor ligands as potential antipsychotics","volume":"11","author":"Kaczor","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110417_bb0110","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.3390\/ijms21228849","article-title":"The antipsychotic D2AAK1 as a memory enhancer for treatment of mental and neurodegenerative diseases","volume":"21","author":"Kosz\u0142a","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0115","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s11064-022-03570-8","article-title":"In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1","volume":"47","author":"Kosz\u0142a","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hlca.19680510204","article-title":"Synthese von 2- und 3-(1,2,3,6-Tetrahydropyridyl)-indolen","volume":"51","author":"Beck","year":"1968","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110417_bb0125","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1021\/jm0498203","article-title":"Synthesis and structure\u2212activity relationships of novel histamine H 1 antagonists: Indolylpiperidinyl benzoic acid derivatives","volume":"47","author":"Fonquerna","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0130","first-page":"470","article-title":"Indole derivatives. X. Synthesis of indolylpipecoline","volume":"20","author":"Tacconi","year":"1965","journal-title":"Farmaco Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0135","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1248\/cpb.41.1589","article-title":"Synthesis and pharmacological properties of N-[4-[4-(1H-Indol-3-yl)-piperidinoalkyl]-2-thiazolyl]alkanesulfonamides as novel Antiallergic agents","volume":"41","author":"Shigenaga","year":"1993","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2026.110417_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jlcr.2580290302","article-title":"Synthesis of 5-(2,3-ditritiopropoxy)-3-(1,2,5,6-tetrahydropyrid-4-yl)indole ([3H]CP-96,501): a selective ligand for the serotonin (5-HT1B) receptor","volume":"29","author":"Macor","year":"1991","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"10.1016\/j.bioorg.2026.110417_bb0145","series-title":"Substituted pyrazoles","author":"Butler","year":"2001"},{"key":"10.1016\/j.bioorg.2026.110417_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2012.07.006","article-title":"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine","volume":"55","author":"Annedi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0155","series-title":"Protein Kinase c Inhibitors","author":"Heath","year":"1994"},{"key":"10.1016\/j.bioorg.2026.110417_bb0160","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1016\/S0040-4020(03)00973-6","article-title":"Strategies for the synthesis of N-(azacycloalkyl)bisindolylmaleimides: selective inhibitors of PKC\u03b2","volume":"59","author":"Faul","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110417_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00397918808057833","article-title":"Simple synthesis of 1-(Azacycloalkyl)indoles using exclusive Ortho \u03b1-Chloroacetylation of N-(Azacycloalkyl)anilines","volume":"18","author":"Sasakura","year":"1988","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110417_bb0170","series-title":"CrysAlisPRO Software System, Version 1.171.35.19","author":"Agilent Technologies","year":"2011"},{"key":"10.1016\/j.bioorg.2026.110417_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows\u00a0: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.bioorg.2026.110417_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2026.110417_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S0021889802022112","article-title":"Single-crystal structure validation with the program PLATON","volume":"36","author":"Spek","year":"2003","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.bioorg.2026.110417_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70232","article-title":"Unveiling the therapeutic potential of D2AAK1 and its derivatives: mechanistic insights and applications in neurodegenerative disease treatment","volume":"169","author":"Jastrz\u0119bski","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072239","article-title":"Screening and structure\u2013activity relationship of D2AAK1 derivatives for potential application in the treatment of neurodegenerative diseases","volume":"27","author":"Kosz\u0142a","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0205","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1021\/ci000383k","article-title":"Robustness of biological activity spectra predicting by computer program PASS for noncongeneric sets of chemical compounds","volume":"40","author":"Poroikov","year":"2000","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110417_bb0215","doi-asserted-by":"crossref","first-page":"W115","DOI":"10.1093\/nar\/gkac313","article-title":"BioTransformer 3.0-a web server for accurately predicting metabolic transformation products","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.110417_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0230","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.3390\/ijms21103411","article-title":"Dual target ligands with 4-tert-Butylphenoxy scaffold as histamine H3 receptor antagonists and monoamine oxidase B inhibitors","volume":"21","author":"\u0141a\u017cewska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0235","series-title":"LigPrep","author":"Schr\u00f6dinger","year":"2021"},{"key":"10.1016\/j.bioorg.2026.110417_bb0240","series-title":"Epik","author":"Schr\u00f6dinger","year":"2019"},{"key":"10.1016\/j.bioorg.2026.110417_bb0245","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ml200196p","article-title":"Molecular insights into human monoamine oxidase B inhibition by the Glitazone anti-diabetes drugs","volume":"3","author":"Binda","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110417_bb0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijbiomac.2022.05.009","article-title":"Crystal structure of human acetylcholinesterase in complex with tacrine: implications for drug discovery","volume":"210","author":"Dileep","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0260","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbr.2016.01.002","article-title":"The positive allosteric modulator of \u03b17 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1\/2 phosphorylation in mice","volume":"302","author":"Targowska-Duda","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105016","article-title":"N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: in vitro, in silico and in vivo evaluation of a multi-target ligand","volume":"146","author":"Kaczor","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2026.110417_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2013.01.038","article-title":"Effects of NOS inhibitors on the benzodiazepines-induced memory impairment of mice in the modified elevated plus-maze task","volume":"244","author":"Orzelska","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0275","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0166-4328(01)00347-3","article-title":"MK-801 induced amnesia for the elevated plus-maze in mice","volume":"131","author":"Hli\u0148\u00e1k","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fnbeh.2015.00183","article-title":"Spontaneous object recognition: a promising approach to the comparative study of memory","volume":"9","author":"Blaser","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0285","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/biom13101449","article-title":"Neonatal maternal separation induces sexual dimorphism in brain development: the influence on amino acid levels and cognitive disorders","volume":"13","author":"Kotlinska","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0290","doi-asserted-by":"crossref","DOI":"10.3791\/55718","article-title":"Novel object recognition test for the investigation of learning and memory in mice","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioorg.2026.110417_bb0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuint.2016.03.003","article-title":"In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic","volume":"96","author":"Kaczor","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2026.110417_bb0300","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejmech.2019.07.050","article-title":"Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs","volume":"180","author":"Kondej","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200238","article-title":"Multitarget derivatives of D2AAK1 as potential antipsychotics: the effect of substitution in the indole moiety","volume":"17","author":"Kondej","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110417_bb0310","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The Cambridge structural database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Crystallogr. B Struct. Sci. Cryst. Eng. Mater."},{"key":"10.1016\/j.bioorg.2026.110417_bb0320","series-title":"International Tables for Crystallography","doi-asserted-by":"crossref","DOI":"10.1107\/97809553602060000621","article-title":"Typical Interatomic Distances: Organic Compounds","author":"Allen","year":"2006"},{"key":"10.1016\/j.bioorg.2026.110417_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104967","article-title":"Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: potential inhibitor of SARS-CoV2","volume":"112","author":"Nandini Asha","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0330","doi-asserted-by":"crossref","first-page":"o2936","DOI":"10.1107\/S160053680602277X","article-title":"3-(4-Methylpiperidin-1-yl)isobenzofuran-1(3H)-one","volume":"62","author":"B\u00fcy\u00fckg\u00fcng\u00f6r","year":"2006","journal-title":"Acta Crystallogr. E: Struct. Rep. Online"},{"key":"10.1016\/j.bioorg.2026.110417_bb0335","doi-asserted-by":"crossref","first-page":"o642","DOI":"10.1107\/S1600536807000396","article-title":"(2-Ethoxyphenyl)[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]methanone","volume":"63","author":"Naveen","year":"2007","journal-title":"Acta Crystallogr. E: Struct. Rep. Online"},{"key":"10.1016\/j.bioorg.2026.110417_bb0340","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/acs.cgd.9b01413","article-title":"Donepezil multicomponent systems: donepezil\u2013water\u2013maleic acid crystals and more","volume":"20","author":"Bae","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.bioorg.2026.110417_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26010080","article-title":"First synthesis of racemic trans Propargylamino-donepezil, a pleiotrope agent able to both inhibit AChE and MAO-B, with potential interest against Alzheimer's disease","volume":"26","author":"Guieu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130998","article-title":"Experimental and computational structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles","volume":"1245","author":"Bartyzel","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110417_bb0355","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/molecules27082479","article-title":"Experimental and computational structural studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted indoles as non-competitive antagonists of GluK1\/GluK2 receptors","volume":"27","author":"Bartyzel","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0360","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/molecules28010383","article-title":"Synthesis, structural and behavioral studies of indole derivatives D2AAK5, D2AAK6 and D2AAK7 as serotonin 5-HT1A and 5-HT2A receptor ligands","volume":"28","author":"Kaczor","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5155\/eurjchem.8.1.1-7.1512","article-title":"Density functional computational and X-ray studies on pharmaceutical compound 1-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-1H-indole","volume":"8","author":"\u015eahin","year":"2017","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0370","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/ja00839a011","article-title":"General definition of ring puckering coordinates","volume":"97","author":"Cremer","year":"1975","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110417_bb0375","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01200485","article-title":"The conformation of six-membered rings","volume":"8","author":"Boeyens","year":"1978","journal-title":"J. Cryst. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110417_bb0380","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/ja00029a013","article-title":"The conformation of six-membered rings described by puckering coordinates derived from endocyclic torsion angles","volume":"114","author":"Haasnoot","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110417_bb0385","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0390","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110417_bb0395","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1016\/j.bmcl.2010.06.128","article-title":"Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening","volume":"20","author":"Geldenhuys","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110417_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184312","article-title":"Design, synthesis, and structure\u2013activity relationships of thiazole analogs as anticholinesterase agents for Alzheimer's disease","volume":"25","author":"Sa\u011fl\u0131k","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110227","article-title":"Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction","volume":"368","author":"Honorio","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.110417_bb0410","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0415","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110417_bb0420","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110417_bb0425","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/molecules29092127","article-title":"Indole-based compounds in the development of anti-neurodegenerative agents","volume":"29","author":"Barresi","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0430","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3390\/molecules29194770","article-title":"Indole derivatives: a versatile scaffold in modern drug discovery\u2014an updated review on their multifaceted therapeutic applications (2020\u20132024)","volume":"29","author":"Mo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110417_bb0435","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.3c02148","article-title":"First-in-class selenium-containing potent serotonin receptor 5-HT6 agents with a beneficial neuroprotective profile against Alzheimer's disease","volume":"67","author":"Pyka","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1331062","article-title":"Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities","volume":"15","author":"Gangwal","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0445","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/bph.16078","article-title":"Novel therapeutic approaches to target neurodegeneration","volume":"180","author":"de la Fuente","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0450","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/med.21794","article-title":"Neurodegenerative disorders\u2014searching for targets and new ways of diseases treatment","volume":"41","author":"Abramov","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110417_bb0455","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70107","article-title":"Emerging molecular targets in neurodegenerative disorders: new avenues for therapeutic intervention","volume":"137","author":"Eroglu","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110417_bb0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11064-005-9036-0","article-title":"NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels","volume":"31","author":"Kiewert","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2026.110417_bb0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.niox.2005.09.005","article-title":"Imidazole derivatives as antioxidants and selective inhibitors of nNOS","volume":"14","author":"Sorrenti","year":"2006","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.bioorg.2026.110417_bb0470","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/antiox10101641","article-title":"Highly potent, selective, and competitive indole-based MAO-B inhibitors protect PC12 cells against 6-Hydroxydopamine- and rotenone-induced oxidative stress","volume":"10","author":"Elsherbeny","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2026.110417_bb0475","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2015.07.047","article-title":"Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype","volume":"102","author":"Santos","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110417_bb0480","series-title":"Carbostyril Derivatives and Antiallergic Agent","author":"Takeshi","year":"1993"},{"key":"10.1016\/j.bioorg.2026.110417_bb0485","series-title":"Philip; Wise, Tryptophan-2,3-Dioxygenase and\/or Indoleamine-2,3-Dioxygenase Inhibitors, WO2016071293A2 WIPO (PCT)","author":"Cowley","year":"2015"},{"key":"10.1016\/j.bioorg.2026.110417_bb0490","series-title":"3-(1,2,3,6-T\u00e9trahydro-(1-alkyl\u00e9nearyl)-4-Pyridinyl)- et 3-(1-Alkylenearyl)-4-pip\u00e9ridinyl-1h-Indoles: Nouveaux Agonistes 5-HT1f","author":"Audia","year":"1995"},{"key":"10.1016\/j.bioorg.2026.110417_bb0495","series-title":"Dipeptides which Promote Release of Growth Hormone","author":"Carpino","year":"1995"},{"key":"10.1016\/j.bioorg.2026.110417_bb0500","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0960-894X(03)00286-5","article-title":"Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKC\u03b2","volume":"13","author":"Faul","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110417_bb0505","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.bmcl.2008.02.059","article-title":"Aryl\u2013indolyl maleimides as inhibitors of CaMKII\u03b4. Part 1: SAR of the aryl region","volume":"18","author":"Levy","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110417_bb0510","series-title":"Pyrrole-2, 5-dione Derivatives and their Use as Gsk-3 Inhibitors","author":"Albaugh","year":"2003"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:11:31Z","timestamp":1791407491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":102,"alternative-id":["S0045206826009533"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110417","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D2AAK1 derivatives as neuroprotective agents: Synthesis and structural and pharmacological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110417"}}